FDA 483 - CASAD Company Inc - October 08, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of CASAD Company Inc, a drug product relabeler in Coldwater, OH, revealed significant deficiencies in quality control and record-keeping. The firm lacked written procedures for managing deviations, corrective actions, and investigations, and failed to document deviations or maintain quality agreements with contract manufacturers. Additionally, the company did not prepare or maintain batch production and control records for any of its relabeled drug products, a critical lapse given the release of numerous batches without such documentation.
- Person
ID · 4dbeb013-bed7-4bdb-939c-cd36c11ffd1d